skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

241 Total results for product and free and sample content found

Meddevicetracker

Meddevicetracker weekly round up 23rd January

By Edward Stopke 23 Jan 2017

Meddevicetracker Weekly News Write-Up, January 23, 2017.

Topics Medtech weekly roundup Medtech

Scrip

IDMA Meet: Trump, Protectionism, New Markets And Cricket

By Anju Ghangurde 23 Jan 2017

The Trump presidency and the threat of protectionism, new generic opportunities beyond the US market, and the need for new quality benchmarks were some of the key issues discussed at the recent annual day celebrations of the Indian Drug Manufacturers’ Association.

Topics Strategy US election

Pharmaprojects

eTheRNA CEO outlines development plan in cancer RNA space

20 Jan 2017

Mike Ward, global director of content for Informa Pharma Intelligence, interviews Dirk Reyn, CEO of eTheRNA, on the sidelines of the BIO-Europe® partnering conference in Cologne, Germany. The pair discusses eTheRNA's emerging cancer immunotherapy pipeline, funding prospects and the next steps for the company—which was founded in 2013—as it looks to expand its business.

Pharmaprojects

BioNTechs Sean Marett explains Genentech deal rationale

19 Jan 2017

Chief operating officer of BioNTech, Sean Marett, talks to Mike Ward, global director of content for Informa Pharma Intelligence, about the German firm's recent co-development deal with Roche company, Genentech. On the sidelines of the recent BIO-Europe® partnering conference, held in Cologne Germany, Marett outlines the benefits of this collaboration, such as access to the US market and regulatory expertise. This deal will be highlighted as part of a deal case study session at The One Nucleus Genesis meeting in London on December 1, 2016.

Pink Sheet

Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’

By derrick-gingery 19 Jan 2017

Incoming president not holding over any FDA political appointees from the Obama administration, but what exactly his stamp on the agency will be remains unclear.

Topics US election FDA

Scrip

The Bully Pulpit: Trump Versus Drug Prices

By Michael McCaughan 18 Jan 2017

Medicare price negotiation is not a new idea – nor is the concept of using the Presidential megaphone to talk down drug prices. Will Trump and Twitter turn it into something bigger?

Topics US election

Trialtrove

Novel Biologics for Asthma: Steps on the Long Road to Therapies for Uncontrolled Asthma

By Laura Runkel 17 Jan 2017

After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized? After many years of research, the first two novel biologics have been filed for approval for uncontrolled, eosinophilic asthma treatment. Will the hope for truly targeted therapies for uncontrolled asthma now be realized?

Pink Sheet

US FDA’s Foreign Inspection Agenda: Visit The 1,000 Facilities It’s Never Seen

By Bowman Cox 17 Jan 2017

Congressional oversight agency urges FDA to make better use of foreign offices with more effective performance measures and staffing goals; GAO notes agency’s progress towards risk-based inspections – and its plan to revisit every site at least once every five years.

Medtech Insight

2017: Year Of The New EU Medtech Regulations: But Is EU Ready?

By Amanda Maxwell 17 Jan 2017

2017 is going to be a pivotal year for EU medtech regulations. We are expecting the new Medical Devices Regulation and IVD Regulation to take effect. But there are some big concerns and uncertainties at the center of it all.

Topics Policy and regulation Medtech

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: